96670 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
CYCLOPHILIN INHIBITORS AND USES THEREOF
#2CANCER THERAPEUTICS
#3Reagents for quantitative mass spectrometry
#4CYCLOTHEONELLAZOLEA, AND SYNTHETIC METHOD THEREFOR, AND APPLICATION METHOD THEREOF
#5TARGETED DELIVERY OF NICOTINAMINDE ADENINE DINUCLEOTIDE SALVAGE PATHWAY INHIBITORS
#6CYTOTOXIC BENZODIAZEPINE DERIVATIVES
#7MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#8REAGENTS FOR QUANTITATIVE MASS SPECTROMETRY
#9Reagents for quantitative mass spectrometry
#10Benzodiazepine derivatives
#11Polypeptide compound, pharmaceutical composition, preparation method and application thereof
#12Cytotoxic benzodiazepine derivatives
#13Proteasome inhibitors
#14AROMATIC-CATIONIC PEPTIDES CONJUGATED TO ANTIOXIDANTS AND THEIR USE IN TREATING COMPLEX REGIONAL PAIN SYNDROME
#15Modulators of melanocortin receptors for the treatment of depression and anxiety
#16N-acyldipeptide derivatives and their uses
#17Tripeptide epoxy ketone protease inhibitors
#18Peptide compound, production method therefor, and use thereof
#19Reagents for quantitative mass spectrometry
#20Cross-linkers and their uses
#21Peptide-Based Quorum Sensing Inhibitors for the Attenuation of Virulence in Staphylococcus Aureus
#22Peptidyl ketoamides as inhibitors of rhomboid proteases
#23Epoxyketone compounds for enzyme inhibition
#24AZAINDOLINE COMPOUNDS AS GRANZYME B INHIBITORS
#25PRODRUG OF AN ICE INHIBITOR
#26Anti-bacterial peptide macrocycles and use thereof
#27Targeted delivery of nicotinamide adenine dinucleotide salvage pathway inhibitors
#28SUGAR-DIPEPTIDE CONJUGATES AS FLAVOR MOLECULES
#29Dipeptide piperidine derivatives
#30Benzodiazepine derivatives
#31DIPEPTIDYL KETOAMIDE COMPOUNDS AND THEIR USE FOR THE TREATMENT AND/OR PREVENTION OF FAT ACCUMULATION
#32Cytotoxic benzodiazepine derivatives
#33Antimicrobial compounds
#34Methylphenidate-Prodrugs, Processes of Making and Using the Same
#35Neuropeptide S receptor (NPSR) agonists
#36Benzodiazepine derivatives
#37PRODRUG OF AN ICE INHIBITOR
#38MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#39Combination of N-acyldipeptide derivatives and retinol, and methods of use thereof
#40Cross-linkers and their uses
#41Dipeptidyl ketoamide compounds and their use for the treatment and/or prevention of fat accumulation
#42Isoform-selective lysine deacetylase inhibitors
#43Reagents for quantitative mass spectrometry
#44Protein having synthetic activity for imidazole dipeptid and production method of imidazole dipeptide
#45NOVEL BENZODIAZEPINE DERIVATIVES
#46Peptide compound, production method therefor, and use thereof
#47Pro-Amb reverse turn restricted bioactive peptide analogues
#48SYNTHETIC PEPTIDES AND ENZYMATIC FORMATION OF INTRACELLULAR HYDROGELS
#49Chemical synthesis and screening of bicyclic peptide libraries
#50CANCER IMAGING AGENT
#51Cytotoxic benzodiazepine derivatives
#52Substrates and inhibitors of prolyl oligopeptidase and methods of use thereof
#53Azaindoline compounds as granzyme B inhibitors
#54Macrocyclic inhibitors of flaviviridae viruses
#55Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy
#56NOVEL BENZODIAZEPINE DERIVATIVES
#57Epoxyketone compounds for enzyme inhibition
#58Cyclic tetrapeptides and therapeutic applications thereof
#59Isobaric mass labels
#60N-acyldipeptide derivatives and their uses
#61Selective caspase inhibitors and uses thereof
#62Method for inhibiting ADAM proteases with cyclic peptides
#63Macrocyclic broad spectrum antibiotics
#64HIGHLY EFFICIENT REVERSE OSMOSIS FILTER
#65Methylphenidate-prodrugs, processes of making and using the same
#66Prodrug of an ICE inhibitor
#67Alpha-oxoacyl amino-caprolactam derivative
#68Tripeptide epoxy ketone protease inhibitors
#69Synthesis of syrbactin proteasome inhibitors
#70HCV protease inhibitors and uses thereof
#71PEPTIDE-BASED QUORUM SENSING INHIBITORS FOR THE ATTENUATION OF VIRULENCE IN STAPHYLOCOCCUS AUREUS
#72Cyclic peptides as ADAM protease inhibitors
#73α-oxoacyl amino-caprolactam derivative
#74Chemical synthesis and screening of bicyclic peptide libraries
#75Cytotoxic benzodiazepine derivatives
#76Method for treatment of GM1 gangliosidosis
#77Methods and compositions using ADAM10 inhibitors to treat bacterial infections
#78Crystal forms of anamorelin
#79Dipeptide and tripeptide epoxy ketone protease inhibitors
#80Cross-linkers and their uses
#81Prodrug of an ice inhibitor
#82Methylphenidate-prodrugs, processes of making and using the same
#83Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#84Derivatives of pyridinone as inhibitors for tissue transglutaminase
#85Substrates and inhibitors of prolyl oligopeptidase and methods of use
#86THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
#87Alanyl glutamine compound and preparation method thereof
#88Cyclin based inhibitors of CDK2 and CDK4
#89Selective caspase inhibitors and uses thereof
#90Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#91Methylphenidate-oxoacid conjugates, processes of making and using the same
#92Cross-linkers and their uses
#93Macrocyclic broad spectrum antibiotics
#94Prodrug of an ice inhibitor
#95Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use
#96MCR dendrimers
#97NOVEL COMPOUNDS AS DPP-IV INHIBITORS AND PROCESS FOR PREPARATION THEREOF
#98Synthesis of syrbactin proteasome inhibitors
#99Peptide clearing agents
#100Therapeutic peptides
#101HCV protease inhibitors and uses thereof
#102INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE
#103Cross-linkers and their uses
#104Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use
#105AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS
#106Peptidomimetic protease inhibitors
#107INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME
#108Methods of treating emesis using growth hormone secretagogues
#109Enantio- and stereo specific synthesis of β-amino-α-hydroxy amides
#110Selective caspase inhibitors and uses thereof
#111ANTIMICROBIAL CATIONIC LIPO-BETA-PEPTIDES
#112Peptidomimetic protease inhibitors
#113MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN ALPHAVBETA3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY
#114Prodrug of an ICE inhibitor
#115Dipeptoid prodrugs and the use thereof
#116AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS
#117Synthetic mimics of mammalian cell surface receptors: method and compositions
#118Radical scavenger and active oxygen eliminating agent
#119Dipeptidyl peptidase IV (DP-IV) compounds
#120Inhibitors of interleukin-1β converting enzyme
#121NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS
#122Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#123METHOD FOR PRODUCING BETA-ALANYL-AMINO ACID OR DERIVATIVE THEREOF
#124Selective caspase inhibitors and uses thereof
#125Deuterated hepatitis C protease inhibitors
#126Inhibitors of interleukin-1 beta converting enzyme
#127Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide
#128Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#129Aminoisoquinoline thrombin inhibitor with improved bioavailability
#130Processes and intermediates for preparing steric compounds
#131SMALL MOLECULE INHIBITORS OF PDZ INTERACTIONS
#132PROTEASE INHIBITION
#133Organic Compounds and their uses
#134Benzodiazepine derivatives
#135Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs
#136COMPOUND MODIFIED WITH GLYCEROL DERIVATIVE
#137SYNTHETIC MIMICS OF MAMMALIAN CELL SURFACE RECEPTORS: METHOD AND COMPOSITIONS
#138RADICAL SCAVENGER AND ACTIVE OXYGEN ELIMINATING AGENT
#139Peptidomimetic protease inhibitors
#140CASPASE INHIBITORS AND USES THEREOF
#141Synthetic peptides reducing or removing bags formed under the lower eye contour and their use in cosmetic or dermopharmaceutical compositions
#142HCV protease inhibitors and uses thereof
#143Compounds and compositions as channel activating protease inhibitors
#144HCV protease inhibitors and uses thereof
#145Synthetic mimics of mammalian cell surface receptors: method and compositions
#146RADIOFLUORINATION METHODS
#147Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy
#148Cross-linkers and their uses
#149Synthetic mimics of mammalian cell surface receptors: method and compositions
#150Methionine aminopeptidase-2 inhibitors and methods of use thereof
#151Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
#152Topical application agents against mimic and age-related wrinkles
#153Inhibitors of caspases
#154Prodrug of an ICE inhibitor
#155Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#156Antibacterial amide macrocycles VII
#157Antibacterial amide macrocycles VI
#158Methods of treating emesis using growth hormone secretagogues
#159OXIMYL DIPEPTIDE HEPATITIS C PROTEASE INHIBITORS
#160Small Molecule Inhibitors of PDZ Interactions
#161Caspase inhibitor prodrugs
#162Beta-peptides with antifungal activity
#163Inhibitors of interleukin-1β converting enzyme
#164Alpha-Keto Carbonyl Calpain Inhibitors
#165Inhibitors of interleukin-1β converting enzyme
#166Peptide Derivative
#167Alpha-Keto Carbonyl Calpain Inhibitors
#168Tripeptide prodrug compounds
#169Processes and intermediates for preparing steric compounds
#170Peptides as NS3-serine protease inhibitors of hepatitis C virus
#171Deuterated hepatitis C protease inhibitors
#172Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
#173Beta-Aminoacid-Derivatives As Factor Xa Inhibitors
#174Pyrrolidine melanocortin-specific compounds
#175Oxidation process for the preparation of N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-{N-[(tert-butylamino)carbonyl]-3-methyl-L-valyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide and related compounds
#176Compounds as inhibitors of hepatitis C virus NS3 serine protease
#177Inactivators and bivalent inhibitors of glyoxalase I and methods of inhibiting tumor growth
#178Therapeutic agents and methods of use thereof for the modulation of angiogenesis
#179Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus
#180Thio-containing inhibitors of aminopeptidase P, and compositions thereof
#181Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
#182Peptides as NS3-serine protease inhibitors of hepatitis C virus
#183Orthogonally protected bifunctional amino acid
#184Methionine aminopeptidase-2 inhibitors and methods of use thereof
#185Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide
#186Peptide derivatives having β-secretase inhibitory activity
#187Asymmetric dosing methods
#188Potentialization of the activation of high molecular weight prodrugs
#189Compound modified with glycerol derivative
#190Antibacterial agents
#191β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
#192Alpha-keto carbonyl calpain inhibitors
#193Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
#194Pentapeptide compounds and uses related thereto
#195Synthetic mimics of mammalian cell surface receptors: method and compositions
#196Therapeutic agents and methods of use thereof for the treatment of melanoma
#197Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
#198Irreversible cysteine protease inhibitors of legumain
#199β-peptoids with antimicrobial activity
#200Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy
#201Inhibitors of the ICE/ced-3 family of cysteine proteases
#202Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors
#203Therapeutic agents and methods of use thereof for the modulation of angiogenesis
#204Low molecular weight peptidomimetic growth hormone secretagogues
#205Hybrid molecules QA, wherein Q is an aminoquinoline and a is an antibiotic or a resistance enzyme inhibitor, their synthesis and their uses as antibacterial agent
#206Granzyme b inhibitors
#207Novel amide derivatives as growth hormone secretagogues
#208Bacterial efflux pump inhibitors and methods of treating bacterial infections
#209Diamines as modulators of chemokine receptor activity
#210Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease
#211Compounds as inhibitors of hepatitis C virus NS3 serine protease
#212Piperidine compounds
#213Caspase inhibitors and uses thereof
#214Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus
#215Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#2163,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease
#217Peptidomimetic protease inhibitors
#218Inhibitors of hepatitis C virus NS3/NS4a serine protease
#219Inhibitors of interleukin-1beta converting enzyme
#220Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#221Therapeutic agents and methods of use thereof for the modulation of angiogenesis
#222Pentapeptide compounds and uses related thereto
#223Compositions of protein mimetics and methods of using same against HIV-1, SARS-coV and the like
#224Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus
#225Inhibitors of the ICE/ced-3 family of cysteine proteases
#226Process and intermediates for the preparation of (1R,2S,5S)-3-azabicyclo[3,1,0]hexane-2-carboxamide, N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[1,1-dimethylethyl]amino]carbonylamino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl
#227Methionine aminopeptidase-2 inhibitors and methods of use thereof
#228Hypoglycaemic peptides and methods of use thereof
#229Tumor antigen
#230Antibacterial agents
#231Pentapeptide compounds and uses related thereto